Molecular mechanisms of tumor-stroma interaction - Pasonen-Seppänen lab
Leaders
Our research focuses on elucidating the molecular and cellular mechanisms underlying tumor–microenvironment interactions, with particular emphasis on the role of inflammation in cancer progression, tumor cell plasticity, and therapeutic resistance. We are especially interested in understanding how immune cells, particularly macrophages, and their secreted factors modulate cancer cell phenotypes and contribute to the development of a pro-tumorigenic microenvironment. Our research investigates the complex interplay between inflammatory signaling, extracellular matrix remodeling, and intercellular communication, including the roles of hyaluronan and extracellular vesicles (EVs) in regulating tumor cell behavior and immune cell functions.
Our studies primarily focus on melanoma and prostate cancer, integrating mechanistic in vitro investigations with translational research utilizing clinical patient cohorts. By combining cellular and molecular approaches with the analysis of tumor tissues and peripheral blood samples, we aim to identify novel molecular mechanisms driving cancer progression and treatment resistance, as well as potential predictive biomarkers of therapeutic response. Ultimately, our research seeks to advance our understanding of tumor biology and contribute to the development of more effective, personalized cancer treatment strategies.
News
-
Pro-inflammatory macrophages increase melanoma cell aggressiveness via extracellular vesiclesPro-inflammatory macrophages increase melanoma cell aggressiveness via extracellular vesicles
-
Inflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cellsInflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cells
-
The 16th FCI Symposium 26.-27.9.2024 - Future of Clinical Decision MakingThe 16th FCI Symposium 26.-27.9.2024 - Future of Clinical Decision Making
-
Cancer and Extracellular vesicles summer school 1.-2.6.2022Cancer and Extracellular vesicles summer school 1.-2.6.2022
Cooperation
-
UEF
-
Lerner Research Institute, Cleveland Clinic, Cleveland, USA
-
UEF
-
UEF, Faculty of Health Sciences
-
Kuopio University Hospital
-
UEF
-
University of Helsinki
-
University of Manchester
-
UEF
Keywords
Leaders
Senior Researchers
Doctoral Researchers
-
Kirsi Kainulainen
Doctoral ResearcherInstitute of Biomedicine, School of Medicine, Faculty of Health Sciences -
Kaisa Mäki-Mantila
Doctoral ResearcherInstitute of Biomedicine, School of Medicine, Faculty of Health Sciences
Technicians
Other group members
Publications
43 items-
Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors
Nurmela, Veera; Schroderus, Anna Mari; Tiainen, Satu; Kuittinen, Outi; Tenhunen, Olli; Jokimäki, Anna; Suoranta, Sanna; Pasonen-Seppänen, Sanna; Sievänen, Tero; Kinnunen, Tuure; Rönkä, Aino, 2026, Cancer immunology immunotherapy, 75, 5, 161. A1 Journal article (refereed), original research -
Extracellular vesicles derived from pro-inflammatory M1 macrophages induce an inflammatory and invasive phenotype in melanoma cells
Mäki-Mantila, Kaisa; Niskanen, Einari A; Kainulainen, Kirsi; Pardas, Laia Puig; Aaltonen, Niina; Wahbi, Wafa; Takabe, Piia; Rönkä, Aino; Rilla, Kirsi; Pasonen-Seppänen, Sanna, 2026, Cell communication and signaling, 24, 1, 10. A1 Journal article (refereed), original research -
The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer
Nurmela, Veera; Juntunen, Anni; Tiainen, Satu; Martikainen, Janne; Pasonen-Seppänen, Sanna; Rönkä, Aino, 2026, Drugs - real world outcomes, 13, 3, 353-362. A1 Journal article (refereed), original research -
Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers
Jokelainen, Otto; Rintala, Teemu; Remes, Satu; Pasonen-Seppänen, Sanna; Nykopp, Timo K.; Sironen, Reijo, 2025, The journal of pathology : Clinical research, 11, 4, e70035. A1 Journal article (refereed), original research -
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events
Nurmela, Veera; Juntunen, Anni; Selander, Tuomas; Pasonen-Seppänen, Sanna; Kuittinen, Outi; Tiainen, Satu; Rönkä, Aino, 2025, Immunotherapy, 17, 5, 339-346. A1 Journal article (refereed), original research -
Differential expression analysis identifies a prognostically significant extracellular matrix–enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma
Jokelainen, Otto; Rintala, Teemu J; Fortino, Vittorio; Pasonen-Seppänen, Sanna; Sironen, Reijo; Nykopp, Timo K, 2024, Scientific reports, 14, 1, 10626. A1 Journal article (refereed), original research -
Expression of Programmed Death Ligand 1 and Indoleamine 2,3‐Dioxygenase in Oral Lichen Planus and Oral Lichenoid Lesions
Kemppainen, Olli; Mathlin, Andreas; Pasonen‐Seppänen, Sanna; Siponen, Maria, 2024, Journal of oral pathology and medicine, 53, 10, 613-621. A1 Journal article (refereed), original research -
Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
Deen, Ashik Jawahar; Adinolfi, Simone; Härkönen, Jouni; Patinen, Tommi; Liu, Xiaonan; Laitinen, Tuomo; Takabe, Piia; Kainulainen, Kirsi; Pasonen-Seppänen, Sanna; Gawriyski, Lisa M; Arasu, Uma Thanigai; Selvarajan, Ilakya; Mäkinen, Petri; Laitinen, Hanna; Kansanen, Emilia; Kaikkonen, Minna U; Poso, Antti; Varjosalo, Markku; Levonen, Anna-Liisa, 2024, Redox biology, 69, 103031. A1 Journal article (refereed), original research -
Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signaling
Kainulainen, Kirsi; Niskanen, Einari A; Kinnunen, Johanna; Mäki-Mantila, Kaisa; Hartikainen, Kiia; Paakinaho, Ville; Malinen, Marjo; Ketola, Kirsi; Pasonen-Seppänen, Sanna, 2024, Oncoimmunology, 13, 1, 2393442. A1 Journal article (refereed), original research -
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Tiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino, 2023, Bmc cancer, 23, 1, 1186. A1 Journal article (refereed), original research